Authors

• Honghong Zou (ORCID: https://orcid.org/0000-0003-0966-6880)
• Wenling Kang
• Gaosi Xu (ORCID: https://orcid.org/0000-0001-5784-6697)
• Kaiping Luo
• Manna Li (ORCID: https://orcid.org/0000-0001-5702-1177)
• Yebei Li (ORCID: https://orcid.org/0000-0002-9453-0621)
• Baoqin Zhou
• Li Wang (ORCID: https://orcid.org/0000-0003-0843-8499)
• Yang Yang (ORCID: https://orcid.org/0000-0002-4840-3023)
• Lijuan Wang (ORCID: https://orcid.org/0000-0002-8195-3713)
• Wenjun Yan (ORCID: https://orcid.org/0000-0003-1933-8733)
• Xiang Li (ORCID: https://orcid.org/0000-0002-9980-9664)
• Shizhang Xu (ORCID: https://orcid.org/0000-0001-5436-6153)

Institutions

• Shangrao Normal University (CN)
• Nanchang University (CN)
• Yichun University (CN)
• Ganzhou People's Hospital (CN)
• Second Affiliated Hospital of Nanchang University (CN)
• Xinyu University (CN)
• First Affiliated Hospital of Gannan Medical University (CN)

Publication Details

Journal

Frontiers in Pharmacology

Published

2025-03-04

DOI

https://doi.org/10.3389/fphar.2025.1496967

Citations

3

Primary Topic

Renal Diseases and Glomerulopathies

Type

article

Field-Weighted Citation Impact

4.29